We are live on ! Find out more
OCUL icon

Ocular Therapeutix
OCUL

75 hedge funds and large institutions have $70.2M invested in Ocular Therapeutix in 2019 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

142% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 12

15% more call options, than puts

Call options by funds: $506K | Put options by funds: $441K

10% more funds holding

Funds holding: 68 → 75 (+7)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

4.08% less ownership

Funds ownership: 53% → 48.92% (-4.1%)

30% less capital invested

Capital invested by funds: $99.9M → $70.2M (-$29.7M)

Holders
75
Holders Change
+7
Holders Change %
+10.29%
% of All Funds
1.64%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
11
Increased
29
Reduced
12
Closed
4
Calls
$506K
Puts
$441K
Net Calls
+$65K
Net Calls Change
-$519K

Top Buyers

Rank Fund Capital Flow
1
DAM
Deltec Asset Management
New York
+$2.65M
2
MWP
MYCIO Wealth Partners
Pennsylvania
+$1.2M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$622K
4
BlackRock
BlackRock
New York
+$592K
5
State Street
State Street
Massachusetts
+$412K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.8M
2
JP Morgan Chase
JP Morgan Chase
New York
-$1.25M
3
Man Group
Man Group
United Kingdom
-$1.11M
4
OM
Opaleye Management
Massachusetts
-$782K
5
Simplex Trading
Simplex Trading
Illinois
-$314K
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
51
Dimensional Fund Advisors
Texas
$35K – – –
State Board of Administration of Florida Retirement System
52
State Board of Administration of Florida Retirement System
Florida
$35K – – –
Deutsche Bank
53
Deutsche Bank
Germany
$34K -$72K -16,099 -58%
GCP
54
GSA Capital Partners
United Kingdom
$34K +$50.2K +11,222 New
Ameriprise
55
Ameriprise
Minnesota
$33K +$49.2K +11,000 New
SG Americas Securities
56
SG Americas Securities
New York
$32K +$47.2K +10,553 New
VF
57
Virtu Financial
New York
$31K +$45.1K +10,085 New
Carson Wealth (CWM LLC)
58
Carson Wealth (CWM LLC)
Nebraska
$28K – – –
Victory Capital Management
59
Victory Capital Management
Texas
$22K +$31.8K +7,115 New
Legal & General Group
60
Legal & General Group
United Kingdom
$20K – – –
BNP Paribas Financial Markets
61
BNP Paribas Financial Markets
France
$18K +$8.32K +1,862 +46%
ACA
62
Atlas Capital Advisors
Wyoming
$15.2K – – –
Group One Trading
63
Group One Trading
Illinois
$15K +$21.9K +4,907 New
CA
64
Centerpoint Advisors
Massachusetts
$8K – – –
AIP
65
Ameritas Investment Partners
Nebraska
$6K – – –
CIAS
66
Capital Investment Advisory Services
North Carolina
$3K – – –
SPIA
67
Steward Partners Investment Advisory
New York
$3K – – –
MAM
68
Meeder Asset Management
Ohio
$3K +$858 +192 +21%
AA
69
AlphaMark Advisors
Kentucky
$3K +$3.98K +890 New
TRCT
70
Tower Research Capital (TRC)
New York
$2K -$5.36K -1,198 -62%
CLOS
71
Compagnie Lombard Odier SCmA
Switzerland
$2K – – –
Daiwa Securities Group
72
Daiwa Securities Group
Japan
$1K – – –
GRP
73
Global Retirement Partners
California
$1K – – –
PFGIA
74
Patriot Financial Group Insurance Agency
Massachusetts
$1K – – –
APA
75
American Portfolios Advisors
New York
$912 – – –
1 2
3
4

OCUL Hedge Fund Activity: Q3 2019 in Review

75 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Ocular Therapeutix (OCUL) for Q3 2019, worth a combined $70.2M — down 30% from $99.9M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new OCUL positions and 4 closed out — a net gain of 7 holders — while 29 added to existing stakes and 12 trimmed.

The largest buyer was Deltec Asset Management, adding an estimated $2.65M. The largest seller was Fidelity Investments, cutting an estimated $1.8M.

  • 75 institutional investors held Ocular Therapeutix (OCUL) as of Q3 2019, up from 68 in Q2 2019.
  • Funds reported $70.2M of Ocular Therapeutix stock for Q3 2019, down 30% quarter-over-quarter.
  • 11 funds opened new Ocular Therapeutix positions in Q3 2019 and 4 closed out, a net change of +7 holders.
  • The largest Ocular Therapeutix buyer in Q3 2019 was Deltec Asset Management, an estimated $2.65M added.
  • The largest Ocular Therapeutix seller in Q3 2019 was Fidelity Investments, an estimated $1.8M sold.

Based on aggregated 13F filings for Q3 2019.